Bill’s story
When the US Food and Drug Administration announced in May 2017 that a new drug had been approved for the treatment of ALS, my father and I were thrilled. He had been diagnosed with the disease a month earlier but had been turned down for exploratory testing, so this was a godsend. What he didn’t…